COOPER COMPANIES, INC. (COO)

71.53 -0.03 (-0.04%)

As of 2025-10-16 19:17:04 EST

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.

Traded asNasdaq: COO
ISINUS2166485019
CIK0000711404
LEI—
EIN942657368
SectorMedical Devices
IndustryOphthalmic Goods
CEOAlbert G. White III
Employees15,000
Fiscal Year End1031
Address6101 BOLLINGER CANYON ROAD, SAN RAMON, CA, 94583
Phone9254603600
Websitehttp://coopercos.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
COOCOOPER COMPANIES, INC.2025-10-16 19:17:0471.53-0.03-0.04
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
COO0000711404COOPER COMPANIES, INC.US2166485019—942657368Nasdaq3851Ophthalmic Goods1031DE6101 BOLLINGER CANYON ROADSAN RAMONCA94583UNITED STATESUS92546036006101 BOLLINGER CANYON ROAD, SAN RAMON, CA, 945836101 BOLLINGER CANYON ROAD, SAN RAMON, CA, 94583COOPER COMPANIES INCMedical Devices1958Albert G. White III15,000http://coopercos.com17,600,000,000217,600,000198,808,921The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.2025-10-10 19:40:48
This is a preview of the latest data. Subscribe to access the full data.
COO Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
COO Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202417,600,000,000-1,200,000,000-6.383199,582,626150,056,644302.9857
202318,800,000,0001,100,000,0006.214749,525,982171,5980.3477
202217,700,000,000-2,500,000,000-12.376249,354,384-53,636-0.1086
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Daniel G. McbrideChief Operating Officer, Executive Vice President2024759,616—3,099,769721,42563,6364,764,859
Holly R. SheffieldPresident2024624,679—2,249,799504,93416,1543,447,463
Albert G. WhitePresident20241,127,692—12,480,0561,702,00816,15415,427,631
Brian G. AndrewsChief Financial Officer, Treasurer, Executive Vice President2024650,000—2,400,194588,56916,1543,727,326
Gerard H. WarnerPresident2024548,718—2,000,048475,16216,1793,128,944
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024400
2023400
2022300
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue3,895,400,0003,593,200,0003,308,400,000
Cost Of Revenue1,299,700,0001,235,300,0001,168,800,000
Gross Profit2,595,700,0002,357,900,0002,139,600,000
Research And Development Expenses155,100,000137,400,000110,300,000
General And Administrative Expenses1,533,700,0001,501,200,0001,342,200,000
Operating Expenses———
Operating Income705,700,000533,100,000507,600,000
Net Income392,300,000294,200,000385,800,000
Earnings Per Share Basic1.975.947.83
Earnings Per Share Diluted1.965.917.76
Weighted Average Shares Outstanding Basic198,900,00049,500,00049,300,000
Weighted Average Shares Outstanding Diluted200,400,00049,800,00049,700,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents107,600,000120,800,000138,200,000
Marketable Securities Current———
Accounts Receivable717,000,000609,700,000557,800,000
Inventories802,700,000735,600,000628,700,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current1,951,500,0001,704,900,0001,533,600,000
Marketable Securities Non Current———
Property Plant And Equipment1,860,500,0001,628,800,0001,413,700,000
Other Assets Non Current660,600,000637,100,000587,900,000
Total Assets Non Current10,363,700,0009,954,000,0009,958,700,000
Total Assets12,315,200,00011,658,900,00011,492,300,000
Accounts Payable260,500,000261,900,000248,800,000
Deferred Revenue129,900,000123,600,00093,600,000
Short Term Debt33,300,00045,400,000412,600,000
Other Liabilities Current424,300,000363,300,000373,100,000
Total Liabilities Current1,022,800,000969,000,0001,280,200,000
Long Term Debt2,550,400,0002,523,800,0002,350,800,000
Other Liabilities Non Current311,600,000239,200,000—
Total Liabilities Non Current3,208,800,0003,138,900,0003,037,400,000
Total Liabilities4,231,600,0004,107,900,0004,317,600,000
Common Stock21,700,0005,400,0005,400,000
Retained Earnings7,268,400,0006,876,100,0006,584,900,000
Accumulated Other Comprehensive Income-421,700,000-453,800,000-466,800,000
Total Shareholders Equity8,083,400,0007,550,800,0007,174,500,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization201,200,000186,200,000179,500,000
Share Based Compensation Expense75,100,00062,100,00054,200,000
Other Non Cash Income Expense———
Change In Accounts Receivable117,100,00060,200,00033,800,000
Change In Inventories59,300,000105,400,00040,400,000
Change In Non Trade Receivables———
Change In Other Assets132,500,00089,400,00016,900,000
Change In Accounts Payable9,300,0005,500,00049,900,000
Change In Other Liabilities3,600,00071,800,00032,400,000
Cash From Operating Activities709,300,000607,500,000692,400,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment421,200,000392,500,000242,000,000
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-764,600,000-449,000,000-1,831,200,000
Tax Withholding For Share Based Compensation30,300,00013,100,00016,800,000
Payments Of Dividends—3,000,0003,000,000
Issuance Of Common Stock8,300,0007,900,0007,200,000
Repurchase Of Common Stock0078,500,000
Issuance Of Long Term Debt3,524,200,0002,124,200,0001,511,000,000
Repayment Of Long Term Debt3,506,800,0001,953,900,000561,500,000
Other Financing Activities55,600,00015,100,0008,900,000
Cash From Financing Activities39,200,000-173,900,0001,193,700,000
Change In Cash-13,200,000-17,700,00042,000,000
Cash At End Of Period107,600,000120,800,000138,200,000
Income Taxes Paid78,400,00067,800,00066,600,000
Interest Paid134,800,000117,500,00049,100,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share1.975.947.83
Price To Earnings Ratio53.137113.12088.7289
Earnings Growth Rate-66.835-24.1379-86.9064
Price Earnings To Growth Ratio-0.795-0.5436-0.1004
Book Value Per Share40.6415152.5455145.5314
Price To Book Ratio2.57570.51090.4696
Ebitda786,200,000653,500,000689,200,000
Enterprise Value23,296,952,0006,306,306,2505,994,731,750
Dividend Yield—0.00080.0009
Dividend Payout Ratio—0.01020.0078
Debt To Equity Ratio0.31960.34030.3852
Capital Expenditures432,900,000401,300,000245,600,000
Free Cash Flow276,400,000206,200,000446,800,000
Return On Equity0.04850.0390.0538
One Year Beta0.7041.0480.984
Three Year Beta0.95950.96130.9131
Five Year Beta0.91450.92020.9068
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Kurzius Lawrence ErikDirector2025-09-292,000A5,777
Warner Gerard H IIIPresident, CooperVision, Inc.2025-09-051,450A18,319
White Albert G IIIDirector, President & CEO2025-09-0510,000A226,151
Andrews Brian GEVP, CFO & Treasurer2025-09-021,525A22,191
McBride Daniel GEVP & Chief Operating Officer2025-09-023,000A63,120
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Rob Bresnahan2025-06-09PA08Sale2025-05-15—$1,001 - $15,000
Thomas Suozzi2022-12-19NY03Sale2017-01-05—$15,001 - $50,000
Alan S. Lowenthal2015-05-02CA47Sale2015-04-20Spouse$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Capital Advisors, Ltd. LLC2025-09-3017,00024469.6721
Burns Matteson Capital Management, LLC2025-09-30402,3105,86868.56
HIGHLAND CAPITAL MANAGEMENT, LLC2025-09-302,934,36842,80068.56
TRUST CO OF TOLEDO NA /OH/2025-09-304,6626868.5588
Blue Trust, Inc.2025-09-3091,1841,33068.5594
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Mid Cap FundCFMCX68,3784,608,335.310.4623
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Mid Cap Select FundCFMSX334,67522,555,421.630.869
Pacer Funds Trust2025-07-31Pacer US Export Leaders ETFPEXL4,673330,334.370.9465
Pacer Funds Trust2025-07-31Pacer Trendpilot US Large Cap ETFPTLC12,360873,728.40.0262
Pacer Funds Trust2025-07-31Pacer MSCI World Industry Advantage ETFGLBL5353.450.0381
This is a preview of the latest data. Subscribe to access the full data.